Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Next-generation agents include CagriSema (semaglutide + cagrilintide, NDA filed December 2025, showing 22.7% weight loss), retatrutide (triple GIP/GLP-1/glucagon agonist, 28.7% weight loss in Phase 3), and orforglipron (oral non-peptide GLP-1, submitted to FDA)
Frenzel and Teschke, 2016)
With tools like a 3D body scan and body fat assessment, we can help you better understand changes in fat distribution, body shape, and overall progress
Tesamorelin is a synthetic analogue of growth hormonereleasing hormone (GHRH)
Retatrutide is still investigational and is not FDA-approved, but this readout matters because it gives the peptide community a more specific map of dose, response, tolerability, and what still needs to be watched
Do I Need a B12 Boost
US$ 29.12
US$ 27.53
US$ 22.42
US$ 27.59
US$ 23.17
US$ 26.46
